1h Free Analyst Time
The antihypertensive drugs market is poised to grow by $5.87 bn during 2022-2026, accelerating at a CAGR of 3.1% during the forecast period. The report on the antihypertensive drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of a wide range of drugs, the rising population with risk factors for hypertension, and increased funds for research on hypertension.
The antihypertensive drugs market analysis includes type segment and geographic landscape.
The antihypertensive drugs market is segmented as below:
By Type
- Systemic hypertension
- Pulmonary hypertension
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the antihypertensive drugs market covers the following areas:
- Antihypertensive drugs market sizing
- Antihypertensive drugs market forecast
- Antihypertensive drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global antihypertensive drugs market: Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Noden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the development of modified release formulations.`
According to the report, one of the major drivers for this market is the availability of a wide range of drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Bausch Health Co Inc
- Bayer AG
- Cipla Ltd.
- Daiichi Sankyo Co. Ltd.
- Dr Reddys Laboratories Ltd
- GlaxoSmithKline Plc
- Hetero Healthcare Ltd.
- Johnson and Johnson
- Lupin Ltd
- Merck and Co. Inc.
- Noden Pharma DAC
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd
- Viatris Inc.
- Zydus Lifesciences Ltd.
